Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Differential associations of age with volume and microstructure of hippocampal subfields in healthy older adults.

Wolf D, Fischer FU, de Flores R, Chételat G, Fellgiebel A.

Hum Brain Mapp. 2015 Jun 24. doi: 10.1002/hbm.22880. [Epub ahead of print]

PMID:
26108449
2.

Brain structural, functional, and cognitive correlates of recent versus remote autobiographical memories in amnestic Mild Cognitive Impairment.

Tomadesso C, Perrotin A, Mutlu J, Mézenge F, Landeau B, Egret S, de la Sayette V, Jonin PY, Eustache F, Desgranges B, Chételat G.

Neuroimage Clin. 2015 May 28;8:473-82. doi: 10.1016/j.nicl.2015.05.010. eCollection 2015.

3.

Anosognosia in Alzheimer disease: Disconnection between memory and self networks.

Perrotin A, Desgranges B, Landeau B, Mézenge F, La Joie R, Egret S, Pélerin A, de la Sayette V, Eustache F, Chételat G.

Ann Neurol. 2015 Jun 18. doi: 10.1002/ana.24462. [Epub ahead of print]

PMID:
26085009
4.

A Cochrane review on brain [18F]FDG PET in dementia: limitations and future perspectives.

Morbelli S, Garibotto V, Van De Giessen E, Arbizu J, Chételat G, Drezgza A, Hesse S, Lammertsma AA, Law I, Pappata' S, Payoux P, Pagani M; European Association of Nuclear Medicine.

Eur J Nucl Med Mol Imaging. 2015 Jun 12. [Epub ahead of print] No abstract available.

PMID:
26067090
5.

Why musical memory can be preserved in advanced Alzheimer's disease.

Jacobsen JH, Stelzer J, Fritz TH, Chételat G, La Joie R, Turner R.

Brain. 2015 Jun 3. pii: awv135. [Epub ahead of print]

PMID:
26041611
6.

Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.

Ossenkoppele R, Jansen WJ, Rabinovici GD, Knol DL, van der Flier WM, van Berckel BN, Scheltens P, Visser PJ; Amyloid PET Study Group, Verfaillie SC, Zwan MD, Adriaanse SM, Lammertsma AA, Barkhof F, Jagust WJ, Miller BL, Rosen HJ, Landau SM, Villemagne VL, Rowe CC, Lee DY, Na DL, Seo SW, Sarazin M, Roe CM, Sabri O, Barthel H, Koglin N, Hodges J, Leyton CE, Vandenberghe R, van Laere K, Drzezga A, Forster S, Grimmer T, Sánchez-Juan P, Carril JM, Mok V, Camus V, Klunk WE, Cohen AD, Meyer PT, Hellwig S, Newberg A, Frederiksen KS, Fleisher AS, Mintun MA, Wolk DA, Nordberg A, Rinne JO, Chételat G, Lleo A, Blesa R, Fortea J, Madsen K, Rodrigue KM, Brooks DJ.

JAMA. 2015 May 19;313(19):1939-49. doi: 10.1001/jama.2015.4669.

PMID:
25988463
7.

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.

Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ; Amyloid Biomarker Study Group, Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BN, Bibeau K, Blennow K, Brooks DJ, van Buchem MA, Camus V, Cavedo E, Chen K, Chetelat G, Cohen AD, Drzezga A, Engelborghs S, Fagan AM, Fladby T, Fleisher AS, van der Flier WM, Ford L, Förster S, Fortea J, Foskett N, Frederiksen KS, Freund-Levi Y, Frisoni GB, Froelich L, Gabryelewicz T, Gill KD, Gkatzima O, Gómez-Tortosa E, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka SK, Hildebrandt H, Ishihara L, Ivanoiu A, Jagust WJ, Johannsen P, Kandimalla R, Kapaki E, Klimkowicz-Mrowiec A, Klunk WE, Köhler S, Koglin N, Kornhuber J, Kramberger MG, Van Laere K, Landau SM, Lee DY, de Leon M, Lisetti V, Lleó A, Madsen K, Maier W, Marcusson J, Mattsson N, de Mendonça A, Meulenbroek O, Meyer PT, Mintun MA, Mok V, Molinuevo JL, Møllergård HM, Morris JC, Mroczko B, Van der Mussele S, Na DL, Newberg A, Nordberg A, Nordlund A, Novak GP, Paraskevas GP, Parnetti L, Perera G, Peters O, Popp J, Prabhakar S, Rabinovici GD, Ramakers IH, Rami L, Resende de Oliveira C, Rinne JO, Rodrigue KM, Rodríguez-Rodríguez E, Roe CM, Rot U, Rowe CC, Rüther E, Sabri O, Sanchez-Juan P, Santana I, Sarazin M, Schröder J, Schütte C, Seo SW, Soetewey F, Soininen H, Spiru L, Struyfs H, Teunissen CE, Tsolaki M, Vandenberghe R, Verbeek MM, Villemagne VL, Vos SJ, van Waalwijk van Doorn LJ, Waldemar G, Wallin A, Wallin ÅK, Wiltfang J, Wolk DA, Zboch M, Zetterberg H.

JAMA. 2015 May 19;313(19):1924-38. doi: 10.1001/jama.2015.4668.

8.

Metabolic connectivity as index of verbal working memory.

Zou N, Chetelat G, Baydogan MG, Li J, Fischer FU, Titov D, Dukart J, Fellgiebel A, Schreckenberger M, Yakushev I.

J Cereb Blood Flow Metab. 2015 Jul;35(7):1122-6. doi: 10.1038/jcbfm.2015.40. Epub 2015 Mar 18.

PMID:
25785830
9.

Quantitative comparison of 21 protocols for labeling hippocampal subfields and parahippocampal subregions in in vivo MRI: towards a harmonized segmentation protocol.

Yushkevich PA, Amaral RS, Augustinack JC, Bender AR, Bernstein JD, Boccardi M, Bocchetta M, Burggren AC, Carr VA, Chakravarty MM, Chételat G, Daugherty AM, Davachi L, Ding SL, Ekstrom A, Geerlings MI, Hassan A, Huang Y, Iglesias JE, La Joie R, Kerchner GA, LaRocque KF, Libby LA, Malykhin N, Mueller SG, Olsen RK, Palombo DJ, Parekh MB, Pluta JB, Preston AR, Pruessner JC, Ranganath C, Raz N, Schlichting ML, Schoemaker D, Singh S, Stark CE, Suthana N, Tompary A, Turowski MM, Van Leemput K, Wagner AD, Wang L, Winterburn JL, Wisse LE, Yassa MA, Zeineh MM; Hippocampal Subfields Group (HSG).

Neuroimage. 2015 May 1;111:526-41. doi: 10.1016/j.neuroimage.2015.01.004. Epub 2015 Jan 14.

PMID:
25596463
10.

Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia.

Fan Z, Aman Y, Ahmed I, Chetelat G, Landeau B, Ray Chaudhuri K, Brooks DJ, Edison P.

Alzheimers Dement. 2015 Jun;11(6):608-621.e7. doi: 10.1016/j.jalz.2014.06.016. Epub 2014 Sep 16.

PMID:
25239737
11.

Effects of age and Alzheimer's disease on hippocampal subfields: comparison between manual and FreeSurfer volumetry.

de Flores R, La Joie R, Landeau B, Perrotin A, Mézenge F, de La Sayette V, Eustache F, Desgranges B, Chételat G.

Hum Brain Mapp. 2015 Feb;36(2):463-74. doi: 10.1002/hbm.22640. Epub 2014 Sep 18.

PMID:
25231681
12.

Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan.

Fouquet M, Besson FL, Gonneaud J, La Joie R, Chételat G.

Neuropsychol Rev. 2014 Sep;24(3):290-9. doi: 10.1007/s11065-014-9263-8. Epub 2014 Aug 22. Review.

PMID:
25146994
13.

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease.

Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Chételat G, Dubois B, Dufouil C, Ellis KA, van der Flier WM, Glodzik L, van Harten AC, de Leon MJ, McHugh P, Mielke MM, Molinuevo JL, Mosconi L, Osorio RS, Perrotin A, Petersen RC, Rabin LA, Rami L, Reisberg B, Rentz DM, Sachdev PS, de la Sayette V, Saykin AJ, Scheltens P, Shulman MB, Slavin MJ, Sperling RA, Stewart R, Uspenskaya O, Vellas B, Visser PJ, Wagner M; Subjective Cognitive Decline Initiative (SCD-I) Working Group.

Alzheimers Dement. 2014 Nov;10(6):844-52. doi: 10.1016/j.jalz.2014.01.001. Epub 2014 May 3.

PMID:
24798886
14.

Intrinsic connectivity identifies the hippocampus as a main crossroad between Alzheimer's and semantic dementia-targeted networks.

La Joie R, Landeau B, Perrotin A, Bejanin A, Egret S, Pélerin A, Mézenge F, Belliard S, de La Sayette V, Eustache F, Desgranges B, Chételat G.

Neuron. 2014 Mar 19;81(6):1417-28. doi: 10.1016/j.neuron.2014.01.026.

15.

Brain activity and functional coupling changes associated with self-reference effect during both encoding and retrieval.

Morel N, Villain N, Rauchs G, Gaubert M, Piolino P, Landeau B, Mézenge F, Desgranges B, Eustache F, Chételat G.

PLoS One. 2014 Mar 7;9(3):e90488. doi: 10.1371/journal.pone.0090488. eCollection 2014.

16.

Relationship between brain volumetric changes and interim drinking at six months in alcohol-dependent patients.

Segobin SH, Chételat G, Le Berre AP, Lannuzel C, Boudehent C, Vabret F, Eustache F, Beaunieux H, Pitel AL.

Alcohol Clin Exp Res. 2014 Mar;38(3):739-48. doi: 10.1111/acer.12300. Epub 2014 Jan 31.

PMID:
24483366
17.

Morphological brain plasticity induced by musical expertise is accompanied by modulation of functional connectivity at rest.

Fauvel B, Groussard M, Chételat G, Fouquet M, Landeau B, Eustache F, Desgranges B, Platel H.

Neuroimage. 2014 Apr 15;90:179-88. doi: 10.1016/j.neuroimage.2013.12.065. Epub 2014 Jan 10.

PMID:
24418502
18.

Hippocampal subfield volumetry in mild cognitive impairment, Alzheimer's disease and semantic dementia.

La Joie R, Perrotin A, de La Sayette V, Egret S, Doeuvre L, Belliard S, Eustache F, Desgranges B, Chételat G.

Neuroimage Clin. 2013 Aug 14;3:155-62. doi: 10.1016/j.nicl.2013.08.007. eCollection 2013.

19.

Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease.

Vandenberghe R, Adamczuk K, Dupont P, Laere KV, Chételat G.

Neuroimage Clin. 2013 Apr 6;2:497-511. doi: 10.1016/j.nicl.2013.03.014. eCollection 2013. Review.

20.

Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease.

Chételat G, La Joie R, Villain N, Perrotin A, de La Sayette V, Eustache F, Vandenberghe R.

Neuroimage Clin. 2013 Mar 5;2:356-65. doi: 10.1016/j.nicl.2013.02.006. eCollection 2013. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk